According to Selecta Biosciences's latest financial reports the company's current revenue (TTM ) is £26.64 Million. In 2022 the company made a revenue of £91.56 Million an increase over the revenue in the year 2021 that were of £63.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.